Taavet+Sten, the investment firm of Wise’s co-founder Taavet Hinrikus and Teleport’s co-founder Sten Tamkivi, has participated in Series A of German-based biotech startup Insempra . Existing investors Swedish EQT Ventures, Berlin-based BlueYard Capital, Munich-based Possible Ventures, and the US Acequia Capital participated in the round. New investors were the German corporate venture fund of international FMCG company Henkel, Henkel dx Ventures, German government-backed Bayern Kapital and the US Alante Capital.